Encision (OTCMKTS:ECIA – Get Free Report) issued its quarterly earnings results on Wednesday. The medical device company reported ($0.03) EPS for the quarter, Zacks reports. Encision had a negative return on equity of 22.33% and a negative net margin of 6.05%.
Encision Stock Performance
Encision stock traded down $0.04 during mid-day trading on Wednesday, reaching $0.15. The company had a trading volume of 5,500 shares, compared to its average volume of 3,924. The company has a 50 day moving average of $0.18 and a 200-day moving average of $0.26. The firm has a market cap of $2.53 million, a price-to-earnings ratio of -5.00 and a beta of 0.87. Encision has a 52 week low of $0.10 and a 52 week high of $0.49. The company has a quick ratio of 0.91, a current ratio of 2.28 and a debt-to-equity ratio of 0.09.
Encision Company Profile
Encision, Inc is a U.S.-based medical device company specializing in the development and commercialization of safety solutions for electrosurgery. Founded in the early 1990s, the company’s core mission is to reduce the risk of unintended thermal injuries during surgical procedures by controlling stray electrical current. Encision’s operations focus on research, design, and manufacturing of proprietary instruments and monitoring systems that integrate seamlessly with existing surgical equipment.
At the heart of Encision’s product offering is its Active Electrode Monitoring (AEM) platform.
Read More
- Five stocks we like better than Encision
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
- They just tried to kill gold
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Encision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encision and related companies with MarketBeat.com's FREE daily email newsletter.
